Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

NCT02244216 ·Status: COMPLETED

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

NCT02238171 ·Status: COMPLETED

Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

NCT02233881 ·Status: COMPLETED

Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease

NCT02238145 ·Status: COMPLETED

Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease

NCT02236715 ·Status: COMPLETED

Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease

NCT02238197 ·Status: COMPLETED

Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

NCT02231372 ·Status: COMPLETED

Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

NCT00267917 ·Status: COMPLETED ·Phase: PHASE4

Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

NCT02238158 ·Status: COMPLETED

Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02173782 ·Status: COMPLETED ·Phase: PHASE3

Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease

NCT02176187 ·Status: TERMINATED ·Phase: PHASE3

Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis

NCT02233920 ·Status: COMPLETED

Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT02238184 ·Status: COMPLETED

Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02176200 ·Status: TERMINATED ·Phase: PHASE3

Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00153075 ·Status: COMPLETED ·Phase: PHASE4

Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease

NCT02233907 ·Status: COMPLETED

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

NCT04078126 ·Status: COMPLETED ·Phase: PHASE3

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers

NCT02359292 ·Status: COMPLETED ·Phase: PHASE1

Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT02172352 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPD

NCT02937584 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

NCT02643082 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT06283966 ·Status: RECRUITING ·Phase: PHASE3

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01204034 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of the Effect of Budesonide on Emphysema

NCT00232674 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00690482 ·Status: COMPLETED ·Phase: PHASE2